Although early reports have suggested an association between circumcision and prostate cancer (PCa) development, results of subsequent epidemiological studies have been conflicting. Here we examine published articles that explore this association.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
We searched MEDLINE through PubMed and Embase for articles reporting on the association between PCa and circumcision, and performed a meta-analysis of qualifying studies.
On the basis of seven reports of case-control studies published from 1971 to 2014, overall findings showed nonsignificant reduced risk (odds ratio (OR) 0. 88, P=0. 19) of PCa in circumcised men compared with uncircumcised men, obtained under heterogeneous conditions (I(2)=65%). Heterogeneity and nonsignificance were erased when the overall effect was subjected to outlier treatment and three studies omitted (OR 0. 90, P=0. 04, I(2)=0%). Furthermore, subgroup analysis showed significantly reduced risks in the following subgroups: (i) post-PSA testing publications (OR 0. 88, P=0. 01), (ii) population-based studies (OR 0. 84, P=0. 05), (iii) studies that collected data by personal interview (OR 0. 83, P=0. 03) and (iv) studies in black race (OR 0. 59, P=0. 02). The strengths of these summary effects lie in the robustness revealed by sensitivity analysis.
Stability of the reduced risks observed in key subgroups suggests that the protective feature of circumcision status against PCa is best seen in the context of the post-PSA testing and population-based studies as well as in the black race subgroup. Prostate Cancer and Prostatic Disease advance online publication, 28 July 2015; doi:10. 1038/pcan. 2015. 34.
Prostate cancer and prostatic diseases. 2015 Jul 28 [Epub ahead of print]
N Pabalan, E Singian, H Jarjanazi, A Paganini-Hill
Center for Research and Development, Angeles University Foundation, Angeles City, Philippines. , Department of Medical Technology, College of Allied Medical Professions, Angeles University Foundation, Angeles City, Philippines. , Environmental Monitoring and Reporting Branch, Ontario Ministry of the Environment and Climate Change, Etobicoke, ON, Canada. , Department of Neurology, University of California, Irvine, CA, USA.